BioSpace News Archive

Lone Star Bio

J&P Cycles Invests in New PTSD Treatment for Vets

Military veterans with PTSD have new Wind Therapy treatment options, provided through a veteran-focused non-profit

October 1, 2018
·
2 min read
Genetown

Hologic Survey Reveals More than Three in Five Women are Unaware that the Density of a Woman’s Breasts Impacts Her Risk for Developing Breast Cancer[1]

Survey commissioned by Company behind the Genius™ 3D Mammography™ exam sheds light on need for education during Breast Cancer Awareness Month

October 1, 2018
·
2 min read
Genetown

BlueRock Therapeutics to Present at 2018 Cell & Gene Meeting on the Mesa

BlueRock Therapeutics, LP today announced its participation in the Cell & Gene Meeting on the Mesa, to be held Oct. 3-5 in La Jolla, Calif.

October 1, 2018
·
3 min read
Pharm Country

Actinium Launches Iomab-ACT Program Offering Its Targeted, Chemo-Free, Lymphodepletion Technology as a Universal Solution to CAR-T Product Developers

Iomab-ACT program provides a single dose, outpatient, targeted lymphodepletion technology with the potential to improve CAR-T access and outcomes

October 1, 2018
·
8 min read
Business

Trait Appoints International Marketing Executive, and former Diageo N.A. President & Chief Marketing Officer, Peter McDonough to Board of Directors

Trait Biosciences Inc. announced today that Peter J. McDonough, one of the world’s leading consumer brand and marketing experts, has joined its Board of Directors, effective immediately.

October 1, 2018
·
5 min read
Biotech Bay

Modis Therapeutics Announces $30M Series A Financing

Modis Therapeutics, Inc., a company developing medicines for patients with rare genetic diseases, announced today a $30M Series A investment

October 1, 2018
·
5 min read
Business

DURECT Corporation Appoints Michael H. Arenberg, J.D., M.B.A. as Chief Financial Officer

DURECT Corporation announced today the appointment of Michael H. Arenberg to the position of Chief Financial Officer, effective October 15, 2018.

October 1, 2018
·
4 min read
Deals

Sangamo and TxCell announce the completion of the acquisition by Sangamo of majority of TxCell ordinary shares

Stéphane Boissel, CEO of TxCell, joins Sangamo as Executive Vice President, Corporate Strategy.

October 1, 2018
·
10 min read
Business

Roswell Park, Research Collaborator Form First-Ever Joint Venture Between U.S. and Cuban Partners

Roswell Park Comprehensive Cancer Center and its Cuban research partner have launched the first-ever joint venture between U.S. and Cuban partners.

October 1, 2018
·
2 min read
Lone Star Bio

Apollo Endosurgery Completes Enrollment for the ORBERA Post Approval Study

Apollo Endosurgery, Inc. today announced completion of enrollment in the ORBERA® Post Approval Study evaluating the ORBERA intragastric balloon.

October 1, 2018
·
5 min read